vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Flywire Corp (FLYW). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $157.5M, roughly 1.1× Flywire Corp). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 34.0%). Over the past eight quarters, Flywire Corp's revenue compounded faster (17.5% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Flywire Corp is a global payment and receivables solutions provider serving core verticals including education, healthcare, travel, and B2B commerce. It offers secure cross-border payment processing, currency conversion, and workflow tools for organizations and payers worldwide.
ESPR vs FLYW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $157.5M |
| Net Profit | — | $33.0K |
| Gross Margin | — | — |
| Operating Margin | 50.6% | -0.6% |
| Net Margin | — | 0.0% |
| Revenue YoY | 143.7% | 34.0% |
| Net Profit YoY | — | 100.2% |
| EPS (diluted) | $0.32 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $157.5M | ||
| Q3 25 | $87.3M | $200.1M | ||
| Q2 25 | $82.4M | $131.9M | ||
| Q1 25 | $65.0M | $133.5M | ||
| Q4 24 | $69.1M | $117.5M | ||
| Q3 24 | $51.6M | $156.8M | ||
| Q2 24 | $73.8M | $103.7M | ||
| Q1 24 | $137.7M | $114.1M |
| Q4 25 | — | $33.0K | ||
| Q3 25 | $-31.3M | $29.6M | ||
| Q2 25 | $-12.7M | $-12.0M | ||
| Q1 25 | $-40.5M | $-4.2M | ||
| Q4 24 | — | $-15.9M | ||
| Q3 24 | $-29.5M | $38.9M | ||
| Q2 24 | $-61.9M | $-13.9M | ||
| Q1 24 | $61.0M | $-6.2M |
| Q4 25 | 50.6% | -0.6% | ||
| Q3 25 | -11.4% | 16.1% | ||
| Q2 25 | 8.6% | -6.8% | ||
| Q1 25 | -34.0% | -8.2% | ||
| Q4 24 | -6.4% | -4.9% | ||
| Q3 24 | -31.0% | 12.9% | ||
| Q2 24 | 3.5% | -15.2% | ||
| Q1 24 | 52.5% | -5.2% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | -35.9% | 14.8% | ||
| Q2 25 | -15.4% | -9.1% | ||
| Q1 25 | -62.2% | -3.1% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | -57.2% | 24.8% | ||
| Q2 24 | -83.9% | -13.4% | ||
| Q1 24 | 44.3% | -5.4% |
| Q4 25 | $0.32 | $0.01 | ||
| Q3 25 | $-0.16 | $0.23 | ||
| Q2 25 | $-0.06 | $-0.10 | ||
| Q1 25 | $-0.21 | $-0.03 | ||
| Q4 24 | $-0.14 | $-0.12 | ||
| Q3 24 | $-0.15 | $0.30 | ||
| Q2 24 | $-0.33 | $-0.11 | ||
| Q1 24 | $0.34 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $355.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $835.2M |
| Total Assets | $465.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $355.0M | ||
| Q3 25 | $92.4M | $377.3M | ||
| Q2 25 | $86.1M | $274.2M | ||
| Q1 25 | $114.6M | $255.3M | ||
| Q4 24 | $144.8M | $611.1M | ||
| Q3 24 | $144.7M | $681.1M | ||
| Q2 24 | $189.3M | $571.0M | ||
| Q1 24 | $226.6M | $619.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $15.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | $835.2M | ||
| Q3 25 | $-451.4M | $829.1M | ||
| Q2 25 | $-433.5M | $792.4M | ||
| Q1 25 | $-426.2M | $784.3M | ||
| Q4 24 | $-388.7M | $814.8M | ||
| Q3 24 | $-370.2M | $843.2M | ||
| Q2 24 | $-344.2M | $802.6M | ||
| Q1 24 | $-294.3M | $-797.0M |
| Q4 25 | $465.9M | $1.3B | ||
| Q3 25 | $364.0M | $1.3B | ||
| Q2 25 | $347.1M | $1.1B | ||
| Q1 25 | $324.0M | $1.1B | ||
| Q4 24 | $343.8M | $1.1B | ||
| Q3 24 | $314.1M | $1.2B | ||
| Q2 24 | $352.3M | $998.7M | ||
| Q1 24 | $373.1M | $998.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $4.9M |
| Free Cash FlowOCF − Capex | — | $4.5M |
| FCF MarginFCF / Revenue | — | 2.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 148.06× |
| TTM Free Cash FlowTrailing 4 quarters | — | $98.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $4.9M | ||
| Q3 25 | $-4.3M | $150.1M | ||
| Q2 25 | $-31.4M | $24.1M | ||
| Q1 25 | $-22.6M | $-78.9M | ||
| Q4 24 | $-35.0M | $-28.6M | ||
| Q3 24 | $-35.3M | $184.6M | ||
| Q2 24 | $-7.2M | $-19.3M | ||
| Q1 24 | $53.8M | $-38.1M |
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $149.9M | ||
| Q2 25 | — | $23.5M | ||
| Q1 25 | — | $-79.1M | ||
| Q4 24 | — | $-28.7M | ||
| Q3 24 | $-35.5M | $184.4M | ||
| Q2 24 | $-7.3M | $-19.7M | ||
| Q1 24 | $53.8M | $-38.3M |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 74.9% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | -59.3% | ||
| Q4 24 | — | -24.4% | ||
| Q3 24 | -68.7% | 117.6% | ||
| Q2 24 | -9.9% | -19.0% | ||
| Q1 24 | 39.0% | -33.6% |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.1% | 0.2% |
| Q4 25 | — | 148.06× | ||
| Q3 25 | — | 5.07× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 4.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FLYW
| Transactions | $126.4M | 80% |
| Platform And Other Revenues | $31.1M | 20% |
